“The Amplify Surgical name better emphasizes our commitment to delivering new surgical solutions that re-establish the standard of care for our surgeon customers and their patients,” explained Andy Choi, CEO. “In addition, the new name and brand better represents the company’s culture and product pipeline.”
In October 2018, the company received U.S. Food and Drug Administration (FDA) clearance for its first product, dualX— the Dual Expanding Interbody Fusion System. DualX is comprised of a family of titanium expandable interbody devices designed to be used in transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF) and lateral lumbar interbody fusion (LLIF) spinal procedures. The product portfolio contains varying footprints, heights and degrees of lordosis with post-expansion bone grafting to provide a customized, anatomical fit for a clinically-successful fusion environment.
The company officially changed its name in January and has begun the rebranding process. The company anticipates the rebranding process will continue through the end of the first quarter.
Amplify Surgical Inc. is a privately-held spinal device company located in Mission Viejo, Calif. The company focuses on developing and commercializing minimally invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.